Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure - PubMed (original) (raw)

Case Reports

. 2019 Aug 1;94(2):296-300.

doi: 10.1002/ccd.28221. Epub 2019 Apr 10.

Affiliations

Case Reports

Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure

Leah Raj et al. Catheter Cardiovasc Interv. 2019.

Abstract

Mixed aortic valve disease refers to the combination of aortic regurgitation (AR) and aortic stenosis (AS). Commonly etiologies include a bicuspid aortic valve, rheumatic heart disease, and endocarditis superimposed upon a stenotic aortic valve. Treatment depends upon the severity of disease, the presence of symptoms and the size and function of the left ventricle. We present a case of a young patient that presented with new onset acute decompensated heart failure with mixed aortic valve disease that was successful treated with transcatheter aortic valve replacement (TAVR). Invasive hemodynamics at baseline and following TAVR provide an insight into the characteristic features of mixed aortic valve disease. TAVR represents a new treatment option for critically ill patients deemed high risk or nonoperable for surgical aortic valve replacement.

Keywords: aortic insufficiency; aortic regurgitation; aortic stenosis; transcatheter aortic valve replacement.

© 2019 Wiley Periodicals, Inc.

PubMed Disclaimer

Publication types

MeSH terms

Supplementary concepts

LinkOut - more resources